10.1530/eje.0.1460863 [DOI] [PubMed] 24.Fadini GP, Bottigliengo D, DAngelo F, Cavalot F, Bossi AC, Zatti G, Baldi I, Avogaro A
This dose produces significant appetite suppression in most users
The maintenance frequency approach offers middle ground where users completing intensive initial treatment (6-12 months daily) transition to reduced frequency (2-4 times weekly) maintaining copper supplementation at lower intensity and cost while avoiding complete discontinuation allowing some benefit decline
It is important to recognize that, while BPC-157 offers unique benefits in laboratory settingssuch as enhanced cell migration, improved tissue repair, and inflammation controlit is not approved for human consumption or as a treatment for any disease
Nature Medicine , 28(5), 898-910